The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 17th 2024
Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
About 200,000 more children have health insurance since the start of the COVID-19 pandemic; if FDA-approved, bivalent COVID-19 vaccines for younger children are expected to become available by early to mid-October; a trial compared metformin plus sitagliptin, liraglutide, glimepiride, and insulin glargine for maintaining blood glucose levels.
Read More
Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review
September 14th 2022Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.
Read More
Review Examines Traditional, Newer Forms of CBT on Diabetes-Related Distress
August 29th 2022While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.
Read More
Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.
Read More
Self-management Vital for Patients With Diabetes Who Have Intellectual Disabilities
August 24th 2022According to this systematic review, the best way to optimize diabetes management for patients with both diabetes and intellectual disabilities is supported self-management, which has numerous obstacles to full implementation.
Read More
Dr Paul Hahn on the Importance of Understanding the Economic Value of DME Treatments
August 12th 2022For vision-threatening diseases, such as diabetic macular edema (DME) understanding the economic value of treatments can help identify the direct and indirect benefits of different treatments, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.
Watch
Activation, Physical Activity, and Outcomes Among Individuals With T2D
This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.
Read More
Budget Bill Allowing Medicare to Negotiate Drug Prices Heads to House
August 8th 2022HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.
Read More
Cardiologists Must “Get Into the Game” With Novel Agents in Patients With Diabetes
August 3rd 2022During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.
Read More
Time-Restricted Eating Improves Glucose Control for Patients With Type 2 Diabetes
July 29th 2022Following a time-restricted eating schedule, limited to a 10-hour window, provides beneficial metabolic effects and the potential for weight loss in patients with type 2 diabetes, according to a new study.
Read More
Risk of T2D From Corticosteroid Exposure Associated With Age, Sex, BMI, Steroid Dose
July 15th 2022A recent study characterized the known association between corticosteroid exposure and type 2 diabetes (T2D), finding risk to be associated with treatment- and patient-related characteristics that can inform prescription of treatment with steroids.
Read More
Diabetes Prevention Programs Go Unused Even as Prediabetes Soars
July 13th 2022Although prediabetes prevalence jumped 4.8 percentage points from 2010 to 2020, barriers to accessing diabetes prevention interventions persist, driven by cost, eligibility requirements, and data integration, leading to low participation rates.
Read More
President Joe Biden will sign an executive order to protect access to the abortion pill and emergency contraception; Governor Gavin Newsom announced California will make low-cost insulin; CMS proposed a rule that would bring major reforms to the accountable care organization program.
Read More
Dr Christopher Thompson Discusses GI Innovation Presented at DDW
June 27th 2022Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal (GI) invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.
Read More
Dr Christopher Thompson Discusses Innovative Treatment for Type 2 Diabetes and Obesity
June 24th 2022Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.
Read More